Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Veritas In Silico Inc. ( (JP:130A) ) just unveiled an announcement.
Veritas In Silico Inc. has announced a slate of board and audit candidates to be voted on at its 10th Annual General Shareholders’ Meeting on March 24, 2026, as the terms of all four current directors and the mandate of the existing alternate audit & supervisory board member expire, and current auditor Sadao Suzuki prepares to retire. The company is proposing the reappointment of four directors including CEO Shingo Nakamura, the new appointment of Tomoko Satoh as director, the designation of Kinichiro Kominami and Satoh as outside and independent directors, the appointment of Eiji Hamano as a new outside and independent auditor replacing Suzuki for the remainder of the current term, and the continuation of Jun Goda as alternate audit & supervisory board member, signaling an emphasis on continuity alongside strengthened independent oversight in its governance structure.
More about Veritas In Silico Inc.
Veritas In Silico Inc., listed on the Tokyo Stock Exchange Growth market, operates in the life sciences and biotechnology sector. The company focuses on leveraging in silico, or computer-based, technologies to support drug discovery and related biomedical research, targeting growth-oriented investors interested in innovative pharmaceutical R&D platforms.
Average Trading Volume: 225,106
Technical Sentiment Signal: Sell
Current Market Cap: Yen3.12B
Find detailed analytics on 130A stock on TipRanks’ Stock Analysis page.